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Abstract:   A health institution-based cross-sectional study was carried out in Shashemene town, 
southern Ethiopia, between September, 1993 and January, 1994 to determine the sero-prevalence 
and the clinical impact of HIV among newly diagnosed tuberculosis patients. The HIV-antibody was 
determined using the two ELISA procedures (Wellcozyme, Wellcome Diagnostics, Dartford Kent 
England, and Du-pont assay, Singapore). A total of 450 tuberculosis patients aged 15 years and 
above were enrolled in the study.  The overall HIV-seroprevalence rate was 44.4%. The highest rate 
was observed in the age group 20-39 years. A slightly higher HIV-infection rate was found in males 
(46%) than in females (41%).  Those divorced and widowed patients had higher proportion of HIV 
sero-positivity.  The HIV positivity rate was higher for extra-pulmonary than pulmonary form of 
tuberculosis (OR = 3.80; 95% CI: 1.49, 9.7 ).  Higher proportions of sputum positive patients were 
HIV-positive compared to the sputum negative pulmonary tuberculosis patients (OR=1.09; 95% CI: 
0.64,1.85) though they manifested typical radiographic features (OR = 7.87; 95% CI: 4.39, 14.21). 
Significant differences were noted among HIV positives than HIV negatives in manifesting herpes 
zoster, lymphadenopathy, oral candidiasis, peripheral paraesthesia and chronic diarrhoea. An 
alternative diagnostic approach is required to avoid missing HIV-related tuberculosis which is 
communicable to the general population. Other findings are discussed and recommendations  made. 
[Ethiop. J. Health Dev. 1997;11(1):51-59]  
  
Introduction  
   Tuberculosis remains a health problem of enormous dimensions, particularly in the developing 
world, affecting millions of people each year.  The pandemic of the acquired immunodeficiency 
syndrome (AIDS) and the evidence of an association between TB and HIV, which causes AIDS is 
now a further cause for world-wide concern (1-4).  
Considering that the great majority of HIV infections occur among the 15-49 year-old,(5,6) and  
assuming that the risks of infection with HIV and tuberculosis are independent, it has been estimated 
that world wide more than 4 million persons, again mostly in the developing countries, have been 
infected with both HIV and Mycobacterium tuberculosis.  
   The most important risk factor yet identified for the development of tuberculosis following 
infection is human immunodeficiency virus infection. Very high incidence rates of TB in dually 
infected individuals have been reported in both industrialized and developing countries (7).  
   In the developing countries, the overlap between HIV infection and tuberculosis is shown by the 
high HIV sero prevalence among patients presenting with active tuberculosis.  Data from a number 
of African countries and Haiti show that sero-prevalence ranges between 17% and 66% (2, 8-12). 
Developing countries are also faced with the problem of the increased cost of tuberculosis treatment  
brought about by the increase in numbers of cases (13).  
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The HIV pandemic will worsen the TB situation in developing countries in three ways over and 
above the existing situation by (a) reactivation of a latent TB infection among dually infected persons 
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(b) new infection with tubercle bacilli and rapid progression to active disease in HIV infected 
persons and (c) increasing the number of cases in the general population whose infection and disease 
is the result of transmission from HIV positive individuals developing TB by either reactivation or 
recent infection (14-16).  
   The influence of HIV-infection on the clinical picture of tuberculosis has been examined by studies 
in Africa (2) and elsewhere (17,18). In Ethiopia one study, conducted among 106 soldiers in 1988, 
has reported a 6.6% seropositivity among TB patients (19). Although a 1990 national tuberculin 
survey has shown  an annual tuberculosis infection rate of 1.4%, and the disease is ranked first as 
cause of death for adults admitted to health care units (20), its relationship to HIV infections has not 
been well studied. The present study was thus undertaken to assess the magnitude of HIV infection 




  This  health institution-based  cross-sectional study was  conducted in Shashemene, a town located 
in southern Ethiopia, between September, 1993 and January, 1994.  The town is found 250 kms  
along the main road from Addis-Ababa to Moyale-Kenya.  It has a wide communication network 
connecting more than four regions of the country.  
   The sources of the study subjects include both inpatient and outpatient departments of Shashemene 
General Hospital, one Health Centre and another two health institutions (Gambo Catholic Hospital 
and Awassa Health Centre) which frequently refer patients to the Shashemene Hospital for the 
antiTB treatment.  All new tuberculosis patients who came seeking the services of the health 
institutions  were included in this study.  New patients with a suspected and/or confirmed diagnosis 
of tuberculosis between September 5, 1993 and January 10, 1994 at the local hospital and health 
centre were entered in the study.  
   The purpose of the study was explained  to the heads of health institutions in the study areas and 
to the clinicians who work there.  Physicians in the health centres and hospitals were asked to refer 
all suspected TB cases to the research team for further investigation of the patient. Accordingly a 
total of 450 newly diagnosed TB patients were enrolled in the study.  
   To maximize efficient  utilization of the  ELISA reagent, patients’ sera were stored at 20oC  in 
Shashemene General Hospital and later analysed according to the Kit manufacturer's instructions.  
   The following operational definitions of tuberculosis were used: confirmed TB diagnosis:  
Pulmonary TB was diagnosed when there are two Acid Fast Bacili( AFB) positive results of sputum 
specimen; or a patient with one sputum specimen positive for AFB and radiologic abnormalities 
consistent with active pulmonary tuberculosis.  Suspect case: patient in whom presumptive diagnosis 
is made on the basis of radiological or other clinical evidence and with negative AFB smear.  New 
case:  patient who was diagnosed with  tuberculosis for the first time. Disseminated TB:  there are 
more than two organs, other than pleural and lymph node, affected by the lesion. HIV-Positivity was 
defined to occur when patients tested positive to the combination of Wellcozyme and Dupont assays.    
A standardized questionnaire was used to collect demographic and clinical information.  Physicians 
from each health institution filled out the questionnaires. In this questionnaire, information  relating 
to their history and clinical examination was completed for each patient, radiological and laboratory 
results were recorded and blood samples taken by laboratory technicians. All patients with 
pulmonary tuberculosis had a chest X-ray.  Radiological features, including the zones involved and 
the presence or absence of cavities, were recorded by the physician at the time of recruitment.  
   Seroprevalence was determined for all new TB patients who were 15 years of age and above, 
irrespective of the  lesion site. All patients with suspected/confirmed TB were enrolled for the 
analysis of clinical presentations.  Patients seen at the health institutions were treated according to 
the national guidelines by the respective health units. Serum samples were analysed for the HIV 
antibody by a competitive recombinant enzyme linked immunosorbent assay (Wellcozyme, 
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Welcome Diagnostics, Dartford, Kent UK) and antiglobulin recombinant ELISA assay ( Dupont, 
Singapore).  There are as yet, no reports of HIV-2 in Ethiopia.  Throughout this text HIV-1 
seropositivity is referred to as HIV-seropositivity.  
   Procedures were performed according to the kit manufacturer's instructions.  Only those 
seropositive on both assays were considered HIV-positive. Studies in Addis Ababa (21), Kenya (22),  
and Zambia (2,23) showed this definition to be concordant with Western-Blot for HIV-1. This 
examination strategy is also supported by a recent WHO report (24).  Sputum was examined for acid 
fast bacilli on direct smear using  Ziehl-Neelsen stain and fluorescence microscopy with a 25 x 
objective and 6.5 x eye pieces.  Serological testings were carried out anonymously, with all clinical 
and laboratory data being identified only by a code number.  
   A chest X-ray was performed for all pulmonary tuberculosis  patients and read by three  general 
practitioners (with similar year of experience)  who have undertaken special training on the radiology 
of the chest to run the tuberculosis follow-up clinics.  
   Data entry and analysis were done using EPI INFO and SAS computer statistical packages. Initial 
analysis of the association between HIV seropositivity and various variables were performed using 
standard 2 x 2 tables.  Further analyses were carried out using logistic regression. Where appropriate, 
Maentel Haenszel Chi-square methods were applied to test for trends.  The odds ratios (OR) 
presented are the antilogs of the logistic regression co-efficient.  Ninety-five percent confidence 
intervals were calculated and statistical significance was designated at P < 0.05.    Patients were 
informed of the study procedures and the tests  to be made during the investigation. Informed verbal 
consent was obtained from each participant. TB treatment was free for all study participants and 
anti-TB drug stock adequate for full course was secured for both study centres. Counselling service 
to be offered to HIV positive patients was organized in collaboration with the Zonal Health 
Department prior to the initiation of the study. The study was approved by the ethical committee of 
both the Department of Community Health and Faculty of Medicine, Addis Ababa University.  
  
Results  
   Between September, 1993 and January, 1994, a total of 450 tuberculosis patients were enrolled in 
the study.  Of the 450 patients there were 269 (60%) males and 181 (40%) females.  The mean age 
of the patients was 30 years.  Most patients 254 (56%) were from Shashemene, 97 (22%) were 
students. Farmers and housewives accounted for 17% each.  The remaining 203 (45%) belonged to 
different other occupations. (Table 1).  
   Overall, 199 (44%) of the patients were positive for HIV. There were nine indeterminate results 
who were negative by Wellcozyme and positive by the Du-pont assay. These patients were 
considered as HIV negatives.  
   As indicated in Table 1, there was no statistical difference in HIV sero-prevalence with regard  to 
age and sex.  However, in the age group of 20-39 and in male patients  HIV positivity was found to 
be higher. The peak sero-prevalence occurred in the age group 20-29 years. Sex was not associated 
with HIV status in these patients when adjusted for age. The adjusted odds ratio (OR) and 95% 
confidence interval (95% CI) were 0.84(0.57, 1.21).  
  There was a statistically significant association between marital status and HIV 
positivity.(OR=0.60, 95% CI :0.40,0.88 p<0.05 ).The association  persisted even after adjusting for 
age and sex. Patients who were widowed/separated or divorced had higher prevalence of HIV 
positivity. Occupational categories which were significantly associated with HIV positivity were 
government employees, prostitutes, merchants, ex-soldiers, and daily labourers.  
  
Table 1: The socio-demographic distribution of HIV positives among tuberclosis patients, southern Ethiopia, 1994.  
  HIV Status    
Age  Posititve  Negative  Adjusted OR (95% CI)  
   15-19                 27(40.9)     39(59.1)    12  
   20-29                 76(47.8)     83(52.2)    1.48 (0.86, 2.56)  
   30-39                 62(46.6)     71(53.4)    1.56 (0.92, 2.64) 
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      ≥40                34(36.9)     8(63.1     1.18 (0.61, 2.25) 
Sex        
   Male                24(46.1)    45(53.9)   0.84 (0.57, 1.2)  
   Female                75(41.4)  06(58.6)   1.00 2  
Marital Status        
   Single               00(50)       03(41)      12  
   Married                79(40)       35(54)      0.60 (0.40, 0.88)  
   Other                   20(10)        13(5)        1.56 (0.73, 3.3)  
Occupation        
   Farmer                 25(33)        50(67)      12  
   Student                32(33)        65(67)      1.98 (0.51, 1.86)  
   Driver                   9(35)        17(65)      1.05 (0.40, 2.7)  
   Hous-wife             27(36)       48(46)      1.12 (0.57, 2.2)  
   Daily labourer       13(52)       12(48)      2.15 (0.85, 5.4)  
   Ex-Soldier             26(55)        21(45)      2.46 (1.16, 5.2)  
   Merchant               22(59)      15(41)       2.91 (1.28, 6.59)  
   Prostitute               9(60)          6(40)      2.97 (1.94, 3.4)  
   Gov’t employee      23(64)       13(36)      3.50 (1.50, 8.1)  
   Other                    13(76)          4(24)      6.5 (1.92 ,  22.1)  
   27(40.9)     39(59.1)    1 
2 
1Adjusted odds ratio and 95% confidence interval.  The logistic regression model included age (4 levels), sex, marital status (3 levels) and occupation 
(10 levels).  
2Referenc category  
  
   Two hundred sixty nine patients were diagnosed as having pulmonary disease on the basis of 
clinical findings, radiographic and/or sputum smear results.  In 128 (48%) of them tubercle bacilli 
were identified by the Ziehl Neelson stain method. In this study, patients with extrapulmonary 
tuberculosis were more likely to be HIV sero-positive than were patients with pulmonary lesions.  
Table 2 shows the relationship between HIV status and site of tuberculosis. Extrapulmonary disease 
(pleural, lymph node, disseminated), both alone and in combination with parenchymal lung disease, 
was strongly associated with HIV infection (OR = 3.92; 95% CI: 1.54, 9.9) P < 0.05.  The association 
persisted when adjusted for age and sex (OR = 3.80  95% CI: 1.49, 9.7) P < 0.05.  The lungs were, 
however, the commonest site of the disease in both HIV positive and negative patients.  
   The overall proportion of hospitalized tuberculosis patients was 29%. Out of these  41% were 
positive for HIV infection, while 46% of the ambulatory TB patients were sero-positive. The 
seroprevalence of HIV infection in hospitalized TB patients was not significantly different from 
those who attended the out-patient department. No significant association between HIV status and 
sputum examination result for AFB was observed in this study.   
  
Table 2: Association between sites of tuberculosis and HIV sero-positivity, southern Ethiopia, 1994.  
  HIV Status    OR (95% CI)  
Positive N=199       Negative N=251  
  
Pulmonary       95    174     11                        12  
Pleural            12       6    3.66(1.33, 10.0)    3.45(1.24  
Disseminated   28      27     1.89(1.05, 3.40)   2.02(1.11  
Lymph node     49     37    2.42(1.47, 3.97)    2.48(1.40  
Pulm + EP       15       7     3.92(1.54, 9.9)     3.80)1.49  
1Adjusted for age and sex by logistic regression.          
2Reference category  
   Chest X-rays were available for all pulmonary TB patients (Table 3).  The chest  X-rays showed 
pulmonary cavitation in 79 (55%) of the HIV negative, but in only 65 (45%) of those HIV-positives. 
(OR = 2.61; 95% CI: 1.49, 4.56, P < 0.05).  In seventy six (52%) of the 174 HIV negative pulmonary  
TB patients upper zone lesions predominated compared with 70 (48%) among the 95 HIV positive 
cases.  (OR = 3.61; 95% CI: 2.02, 6.48, P < 0.05).  When the association between HIV status and 
AFB sputum smear were positivty stratified for the presence of cavitation and superior segment 
involvement, trends were still present, but were less marked and were not statistically significant.    
As shown in Table 4, patients who had upper lobe infiltration appear to be nearly equally divided 
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between sputum smear positives and negatives; and most sputum positives appeared to have 
pulmonary cavitation (OR = 7.87; 95% CI: 4.39, 14.21).  
  
Table 3: Radiographic findings in cases with pulmonary tuberculosis in relation to HIV infection, southern Ethiopia, 1994. X-ray 
findings    HIV Positive  No (%)    HIV Negative No (%) Adjusted2 OR (95% CI)  
 n=95             n=174              
Upper zones only  
      
   Yes                     70(48)     76(52)      1.002  
   No                      25(20)     98(80)     3.61(2.02, 6.48)  
Middle/Lower Zone        
   Included               35(30      80(70)    1.002  
   Not Included         60(39)     94(61)     0.69(.40, 1.18)  
Cavitation        
   Present               65(45)     79(55)     1.002  
   Absent              30(24)     95(76)     .61(1.49, 4.56) 
1Adjusted for age and sex by logistic regression.  
2Reference category  
  
   Table 5, shows the relationship between symptoms and signs at presentation and HIV status. A 
significant number of sero-negative TB patients had complained of cough and fever. Prolonged 
history of cough and fever was also reported by a large proportion of TB patients.  There was no 
significant difference in the history of marked weight loss and organomegaly among the HIV 
positive and negative patients. A large proportion of patients who presented with lymphadenopathy 
were positive for HIV.  
   Clinical signs and symptoms  which showed an association with HIV infection were generalized 
lymphadenopathy, oral candidiasis,  herpes zoster, chronic diarrhoea and paraesthesia. Sputum 
positive tuberculous patients showed a slight difference from sputum negatives in the development 
of fever.  Most sputum negative patients had a more prolonged fever than the others.  Large numbers 
of sputum negative patients tended to manifest with chronic cough than smear positive  patients ( x² 
= 29.15; df = 2, P <0.001).  
  
Discussion  
   The sero-prevalence rate of 44.4% in this study is consistent with other studies conducted in Sub- 
Saharan Africa, the Caribbean and in some urban areas of the United States that have shown  2060% 
of tuberculosis patients to be HIV sero-positive (3,4).  However this rate is much higher than that 
previously reported from testing of 106 Ethiopian soldiers in 1990  
  
(19).  This marked difference could be attributed to study size differences and to the  rapid 
dissemination of HIV infection over time, with essential consideration of the time of introduction of 
the virus in the country and the level of immune compromise.  Although evidence on the proportion 
of HIV/AIDS patients who developed tuberculosis is required this study partly supports the new 
HIV/AIDS case definition for Ethiopia which considers TB as a major criterion.  
Table 4: Association between sputum smear positivity and radiographic appearances among pulmonary TB patients, southern Ethiopia, 
1994.  
  Sputum for AFB   Adjusted
1 OR (95% CI)  
  Positive  Negative    
Cavity  
      
   Present         00(69)    44(31)     12  
   Absent         28(22)    97(78)     7.87(4.39, 14,21)  
Upper zone involvement        
                                                          
1 Adjusted for age and sex by logistic regression.               2Reference category     
   The sero-prevalence of HIV-infection in hospitalized TB patients was not significantly different 
from those attending the out-patient department. However, inferences regarding the prevalence of  
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   Yes              52(52)    48(48)    12  
   No               76(44)    93(56)   .33(0.78, 2.24) 
1Adjusted for age and sex by logistic regression.         
2Reference category  
   The findings in this study are also in conformity with the other observations that have been noted 
in the USA, Europe and Africa (1,2,5-12).  
   The higher sero-positivity observed in this study among the age group 20-39 years is comparable 
with other African studies (2,6,8,13).  The younger ages at which sero-reactive persons developed 
tuberculosis probably reflects the age prevalence of HIV sero-positive persons in the community, as 
it is similar to that reported from the surveillance data in this country (21).  
   Distribution of HIV positivity across the various occupatons in this study indicates the wider 
distribution of the infection in the community. Accordingly, the practice of concentrating on specific 
groups of the population while addressing health education deserves re-consideration.    
   The association of HIV infection with marital status  is compatible with the known transmission 
dynamics of HIV.  Being single has a higher risk of acquiring the infection.  
Table 5: HIV sero-positivity and selected clinical findings among tuberculosis patients, southern Ethiopia, 1994.   
Clinical Findings     HIV +ve     
No (%)   
(n=199)           
HIV -ve   
No (%)      
(n=251)  
Adjusted1 OR (95% CI)  
  
Candidiasis  
      
   Present               12(6)            5(2)         3.16(1.02, 10.4) 0.02  
   Absent               187(94)      246(98)     1 2  
Lymphadenophaty        
   Absent               58(29)       51(20)       1.61(1.02, 2.55) 0.03  
   Present              141(71)       200(80)     1.00 2  
Herpes Zoster        
   Absent                 14(7)            6(2)        3.46(1.21, 10.3) 0.008  
   Present              185(93)       245(98)      1.00 2   
Hepatomegaly        
   Present               35(18)          52(21)      0.82(0.49, 1.35) 0.40  
   Absent              164(82)       199(79)      1.00 2   
Splenomegaly        
   Present             164(15)       199(79)      1.22(1.74, 2.03) 0.40  
   Absent               35(85)         52(21)      1.00 2  
Paraesthesia        
   Present               30(15)        17(7)        2.44(1.25, 4.80) 0.004  
   Absent             164(85)       234(93)      1.00 2   
Marked weight loss        
   Present            124(62)       155(62)      1.02(0.69, 1.53 0.09  
   Absent               75(38)         96(38)      1.00 2  
Fever        
   None                   8(4)           10(4)         1.002  
   < one month      67(34)        92(36)        0.91(0.34, 2.4) 0.5  
   ≥One month    
124(62)      149(59)        1.04(0.39, 27)  
Cough        
   None                  40(20)         40(16)       1.002  
 <one month         35(18)         42(17)       0.83(0.44, 1.56) 0.45  
≥one month       124(62)       196(67)       0.73(0.44, 2.04)  
Diarrhea        
   None             53(77)         221(88)      1.002   
<one month          32(16)          18(7)        2.56(1.39, 4.74) 0.008  
≥one month            14(7)            12(5)        1.68(0.75, 3.74) 
HIV infection in hospitalized TB patients depends on many factors that may have changed over time, 
such as HIV specific mortality rates and criteria for hospital admission and discharge.  Examination 
of this variation between the two sources of TB patients is required through further study.  
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   In this study 29% of the patients with tuberculosis were admitted to the hospital for anti-TB 
treatment. This indicates the effect of HIV on work load of hospitals.  The impact of HIV on resource 
utilization like hospital beds, diagnostic investigations  and therapies has been studied elsewhere 
(16).  This also reinforces the importance of educating all personnel involved in health care to take 
precautions against occupational exposure to HIV with all patients and to avoid possible nosocomial 
infections.  In the absence of rapid and effective interventions, increasing numbers of HIV/TB cases 
are likely to occur and affect  hospital admissions in Ethiopia.  
   In this study the lung was the commonest site of disease in both HIV positive and negative patients.  
Only 23% of HIV positive patients had positive sputum smears.  Even though the absolute number 
of 46 was much less than the number of sputum-positive  HIV negative cases, the role of HIV for 
the spread of the disease in the community should not be underestimated. Since pulmonary disease 
is probably more important in the transmission, the contribution of HIV positive TB patients to the 
spread of the disease is likely to be greater despite this association of HIV with extrapulmonary 
disease.  
   The proportion of HIV positive TB patients who had extrapulmonary infection alone (35%) was 
similar with that reported in a cohort study in Zambia (23), but was higher than other studies done 
in Zaire, Haiti and Ivory coast (2,11,12).   This difference could have resulted from bias towards 
pulmonary disease during recruitment in those studies which were conducted at TB referral centres. 
Lymphadenopathy remains the most frequent form of extrapulmonary TB as reported from Central 
Africa Republic, Kenya, Zambia and Brazil (6). A study from Zaire also showed that patients with 
suspected TB and with extrapulmonary TB had higher HIV seropositivity rates than patients with 
sputum confirmed TB (2).  This fact should be seen in  the light of an essential consideration; i.e., a 
general shift of trend from pulmonary to extrapulmonary tuberculosis in the present HIV/AIDS era, 
thus leading to diagnostic difficulties by challenging/impeding the available diagnostic possibilities.    
Similar to other evidences obtained (2,11,22), there was no appreciable difference in HIV 
seropositivity among sputum smear positive and negative pulmonary TB patients. Similar findings 
were reported elsewhere (2,11,22), although others have reported a tendency for HIV positive 
patients to have a negative sputum smear (9).  This variation may account for the level of immuno-
deficiency posed by HIV infection and prior exposure to TB. The negative sputum smear among 
HIV positive patients probably indicates that HIV positive TB patients may frequently have dry 
cough.  The TB  detection rate based on sputum smear examination may thus be comparable to that 
described for HIV sero- negative patients, at least during the early stages of HIV disease (6).  
   The classic form of TB, with cavitating, upper zone, pulmonary lesions, is known to be determined 
by the interaction between the bacillus and the host's immune system so that, in the presence of 
immuno-deficiency, a different outcome may be expected (8).  
   In this study pulmonary cavitation was observed more often in HIV sero-negative TB patients 
when compared with HIV sero-positive TB patients. This finding is incompatible with other reports 
(2,6), and could be explained by the low grade immuno-depression in the study subjects, leading to 
the typical cavitary lesion. Similar findings have been reported (26,27) attributing the lesion to the 
interaction between the bacillus and the host's immune system.    
   In contrast to other evidence elsewhere (6,26,27) this study  revealed that most HIV negative 
patients with pulmonary tuberculosis tend to have the classic upper lobe involvement. However, a 
large proportion of HIV positive patients had atypical presentation having supplementary 
middle/lower zone involvement and non cavitary appearance. These findings further strengthen the 
distorted radiographic appearance of TB  patients which was established elsewhere (6).  
   A discrepancy between pulmonary cavitation, sputum positivity and upper lobe involvement was 
observed in this study.  All sputum positive cases did not show cavitation and /or upper segment 
involvement.  It has been observed that even in the absence of cavitation the profound impairment 
of the immunity seen in HIV infection may permit tubercle bacilli to multiply in such large numbers 
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as to become visible on smear examination (11).  Therefore the above finding could probably be a 
reflection of this phenomenon.  
   Both tuberculosis and HIV infection lead to chronic ill-health and wasting, and both are associated 
with persistent cough and fever.  These characteristics were also seen in this study, illustrating the 
difficulties in clinical diagnosis.  Patients with tuberculosis, with or without HIV infection, might be 
diagnosed as having HIV/AIDS alone and might therefore fail to receive the anti-TB treatment.    
This study  examined the impact of HIV on the process of diagnosis of TB.  Symptoms of TB were 
comparable in both groups.  HIV positive and negative patients, had similar complaints of cough, 
although fever was more frequent and of longer duration in HIV positives.  
 The presence of generalized lymphadenopathy, peripheral paraesthesia, herpes zoster, oral 
candidiasis and diarrhoea may assist in identifying patients with dual infection with tuberculosis and 
HIV but do not contribute to the diagnosis of TB itself.  The lack of association between HIV and 
prolonged diarrhoea in this study could be attributed to possible recall bias.  The tendency of sputum 
smear negative patients to manifest with prolonged cough and fever further threatens the sputum 
detection rate, thus compounding the difficulty of clinical diagnosis of pulmonary tuberculosis.    In 
the absence of a quick and cheap diagnostic test, physicians may be obliged to treat patients with 
prolonged fever, cough, weight loss, negative sputum smear for acid fast bacilli and failure to 
respond to standard antibiotics, as tuberculosis cases without confirmation of the diagnosis.    It is 
worth  mentioning that this cross-sectional study lacks information about the role of HIV infection 
on tuberculosis relapse.  A longitudinal design is required to address this issue.  
   It is to be noted that there are certain limitations to the study. The nature of the study itself has 
limited the collection of complete information from the patients regarding the clinical signs and 
symptoms. Nevertheless, since all new tuberculosis patients seen at the health institutions during the 
study period were included in the study, and the physicians involved in clinical examination of 
patients were the same, it is assumed that in general, the information obtained was comparable for 
all patients. Confirmation of TB diagnosis was not possible because of the inherent limitation of the 
diagnostic tests.  Lymph node biopsy could not be done for logistic reasons. But it is unlikely that 
the limitations pointed out would  compromise the main findings of the study.  
   The urban-rural mix of the study subjects and uniformity of the selection criteria used for enroling 
new TB patients with adequate sample size permits the internal validity and wider generalizability 
of the study findings.  
   In conclusion, the results show a high prevalence of HIV infection among tuberculosis patients.  
The results also show the difficulties of  clinical diagnosis of co-infected patients who manifested 
unusual clinical, laboratory and radiographic features.  A diagnostic approach with a higher degree 
of diagnostic ability is requ ired to avoid missing HIV-related tuberculosis which is communicable 
to the general population.  
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